Signal from the log
OmicsBank
2,25 M$
Société qui vend aux laboratoires pharmaceutiques l'accès à des données de patients collectées hors des États-Unis. Le tour de 2,25 M$ est rapporté par Endpoints, dont l'article est payant, et aucun fonds n'a pu être vérifié sur une source primaire.
Spotted
Announced on , logged by the watch of 25 August 2026.
- Operation
- Funding round
- Announced amount
- 2,25 M$
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source endpoints
Logged on 25 August 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.